Business Context and Reporting Period
Company: Harvard Bioscience, Inc. (HBIO)
Filing Type: Form 8-K (Current Report)
Date of Report: November 5, 2020
Reporting Period: The filing announces financial results for the three and nine months ended September 30, 2020.
Key Financial Metrics
The provided text serves as a cover report referencing a press release (Exhibit 99.1) for detailed figures. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific data regarding material changes versus prior periods. It only confirms the issuance of results for the period ended September 30, 2020.
Guidance, Outlook, and Management Commentary
Management Action: The Company issued a press release on November 5, 2020, detailing the financial results.
Conference Call: A conference call was scheduled for 8:00 AM EST on November 5, 2020, to discuss the results.
Legal Disclaimer: The information in Item 2.02 and the attached press release is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the three and nine months ended September 30, 2020.
- Verify year-over-year comparisons and margin trends in the referenced press release.
- Check for any forward-looking guidance or updated outlook provided during the November 5, 2020 conference call.
- Confirm the status of the company's liquidity and debt obligations as detailed in the full financial statements referenced in the press release.